Vogue Commercial Co. Ltd Income Statement-Accretion Pharmaceuticals Ltd | BFSL

INCOME STATEMENT

You can view the income statement for the last 5 years.
Accretion Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]89.6357.3833.6729.3822.29
Total Operating Revenues89.6357.3833.6729.3822.29
      
Other Income0.190.090.270.150.29
Total Revenue89.8257.4733.9429.5322.58
      
EXPENSES     
Cost Of Materials Consumed69.4243.7125.0623.6618.61
Changes In Inventories Of FG,WIP And Stock-In Trade-4.26-3.80-3.45-0.31-1.05
Employee Benefit Expenses4.493.672.622.471.96
Finance Costs0.851.441.151.081.02
Depreciation And Amortisation Expenses1.210.770.850.920.81
Other Expenses5.041.911.951.571.13
Total Expenses76.7347.7128.1829.3922.48
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax13.089.765.760.140.10
      
Profit/Loss Before Tax13.089.765.760.140.10
      
Tax Expenses-Continued Operations     
Current Tax3.422.601.860.040.02
Deferred Tax0.000.190.030.000.00
Tax For Earlier Years0.000.180.000.000.00
Total Tax Expenses3.422.971.890.030.03
Profit/Loss After Tax And Before ExtraOrdinary Items9.676.793.880.100.08
      
Profit/Loss From Continuing Operations9.676.793.880.100.08
      
Profit/Loss For The Period9.676.793.880.100.08
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)9.038.489.690.000.00
Diluted EPS (Rs.)9.038.489.690.000.00
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]89.63
Total Operating Revenues89.63
Other Income0.19
Total Revenue89.82
EXPENSES 
Cost Of Materials Consumed69.42
Changes In Inventories Of FG,WIP And Stock-In Trade-4.26
Employee Benefit Expenses4.49
Finance Costs0.85
Depreciation And Amortisation Expenses1.21
Other Expenses5.04
Total Expenses76.73
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax13.08
Profit/Loss Before Tax13.08
Tax Expenses-Continued Operations 
Current Tax3.42
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses3.42
Profit/Loss After Tax And Before ExtraOrdinary Items9.67
Profit/Loss From Continuing Operations9.67
Profit/Loss For The Period9.67
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)9.03
Diluted EPS (Rs.)9.03